Abstract
Abnormal combustions occurred since the invention of internal combustion engines. Knock was intensively studied by researchers and engineers since this date. First patents were taken out on fuel quality (defined by octane index nowadays). After patents on sensors itself, engine settings were piloted to eliminate knock conditions in 1979-1980. Many companies followed this pathway. Latest patents on knock are reviewed. A highlight on a preventive protection (open loop control) is proposed for stationary engines fuelled natural gas, see Le Corre et al. [1]: this patent is a new concept in rupture with curative protection (closed loop control). Preventive protection is based on a gas quality sensor.
Keywords: Knock protection, abnormal combustions, internal combustion engine
Recent Patents on Engineering
Title: Abnormal Combustions in Internal Combustion Engines: Review on the Latest Patents Eliminating Knock Conditions
Volume: 4 Issue: 2
Author(s): O. Le Corre
Affiliation:
Keywords: Knock protection, abnormal combustions, internal combustion engine
Abstract: Abnormal combustions occurred since the invention of internal combustion engines. Knock was intensively studied by researchers and engineers since this date. First patents were taken out on fuel quality (defined by octane index nowadays). After patents on sensors itself, engine settings were piloted to eliminate knock conditions in 1979-1980. Many companies followed this pathway. Latest patents on knock are reviewed. A highlight on a preventive protection (open loop control) is proposed for stationary engines fuelled natural gas, see Le Corre et al. [1]: this patent is a new concept in rupture with curative protection (closed loop control). Preventive protection is based on a gas quality sensor.
Export Options
About this article
Cite this article as:
Le Corre O., Abnormal Combustions in Internal Combustion Engines: Review on the Latest Patents Eliminating Knock Conditions, Recent Patents on Engineering 2010; 4 (2) . https://dx.doi.org/10.2174/187221210791233407
DOI https://dx.doi.org/10.2174/187221210791233407 |
Print ISSN 1872-2121 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-4047 |

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Innate Immunity and the Heart
Current Pharmaceutical Design Inflammatory Mechanisms of Adverse Reactions to BMS
Current Vascular Pharmacology The Pleiotropic Effects of Statins in Endocrine Disorders
Endocrine, Metabolic & Immune Disorders - Drug Targets Relevance of Dopamine D2/Neurotensin NTS1 and NMDA/Neurotensin NTS1 Receptor Interaction in Psychiatric and Neurodegenerative Disorders
Current Medicinal Chemistry Monocyte as an Emerging Tool for Targeted Drug Delivery: A Review
Current Pharmaceutical Design Patent Selections
Recent Patents on Cardiovascular Drug Discovery Pharmacological Strategies Against Glucocorticoid-mediated Brain Damage During Chronic Disorders
Recent Patents on CNS Drug Discovery (Discontinued) CDKN2B-AS1: An Indispensable Long Non-coding RNA in Multiple Diseases
Current Pharmaceutical Design Similarities and Differences Between Carotid Artery and Coronary Artery Function
Current Cardiology Reviews Molecular Targets of Rheumatoid Arthritis
Inflammation & Allergy - Drug Targets (Discontinued) Patent Selections
Recent Patents on Cardiovascular Drug Discovery Implications for Endothelium-Derived Hyperpolarizing Factor (EDHF) in Womens Cardiovascular Health
Current Women`s Health Reviews Chemistry and Pharmacology of Bioactive Molecule -Coenzyme Q10: A Brief Note
Current Bioactive Compounds The Role of Melatonin in Pancreatic Protection: Could Melatonin be Used in the Treatment of Acute Pancreatitis?
Current Pharmaceutical Design Involvement of Toll-like Receptors in Ischemia-induced Neuronal Damage
Central Nervous System Agents in Medicinal Chemistry Meet Our Editorial Board Member
Reviews on Recent Clinical Trials Medical Therapy of Aortic Aneurysms: A Pathophysiology-Based Approach
Current Vascular Pharmacology Myths and Facts Concerning the Use of Statins in Very Old Patients
Cardiovascular & Hematological Disorders-Drug Targets Lysophosphatidic Acid and Renal Fibrosis
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) Ischemic Tolerance Induced by Normobaric Hyperoxia and Evaluation of Group I and II Metabotropic Glutamate Receptors
Current Neurovascular Research